Skye® Biologics is a specialty biomedical company focused on developing innovative and premium medical biologics solutions to advance the field of regenerative medicine.
A LEADER IN NATURAL TISSUE BIOLOGICS
Located in Southern California since 2005, Skye Biologics is a specialty biomedical company. Our mission is to continuously identify, innovate, collaborate and bioengineer improved products through our proprietary manufacturing technology, to advance the field of natural human tissue biologics. We strive to provide surgeons with the best biologic solutions to assist in the natural regenerative process of the body’s tissues and musculoskeletal system, across all treatment settings. Our products assist in preventative therapy, surgical treatment, and post-operative care.
LEADING AMNIOTIC AND PLACENTAL TISSUE PRODUCTS
Skye and it’s affiliates control the processing of our amniotic membrane and placental tissue allografts in-house, from our donation and collection programs through to our unique and innovative HydraTek® Process. Over 100,000 implants have been processed with proprietary HydraTek® technology, helping to achieve dramatically improved clinical outcomes in a range of specialties including wound care, foot and ankle, orthopaedics, spine, sports medicine, gynaecology, urology, otolaryngology, plastic surgery and ophthalmology.
ONE SOURCE FOR ALL YOUR ALLOGRAFT NEEDS
Skye Biologics provides facilities with a complete line of human tissue biologics, including our premium placental tissue line, bone fillers, structural spinal grafts and sports medicine soft tissue allografts. Our one-source solution allows facilities to access all biologic tissues through a single customer service department and reduce the complication of multiple vendors.
Skye has a leading team of seasoned biologics executives, with over 100+ years of experience in all aspects of human biologic product development, processing and distribution. Our team has developed and brought to market various biologic lines, including a unique line of spinal structural allografts, pure demineralized bone matrix putty formulations, and the industry’s most comprehensive line of human amniotic and placental based allografts.
RESEARCH & DEVELOPMENT
Skye has a multi-disciplinary product development team, including R&D, clinical experts and leading scientists. This group focuses on creating human allograft solutions to fit the needs of physicians and enhance the delivery and handling across a wide range of surgical challenges.
The Skye quality control and regulatory team has managed some of the country’s largest tissue banks for over 20 years. This experience is instrumental in the establishment and of our state of the art processing facility.